MARKET

CLSD

CLSD

Clearside Biomed
NASDAQ
0.8588
+0.0097
+1.14%
After Hours: 0.8899 +0.0311 +3.62% 17:21 05/09 EDT
OPEN
0.8700
PREV CLOSE
0.8491
HIGH
0.8798
LOW
0.8101
VOLUME
77.85K
TURNOVER
--
52 WEEK HIGH
1.650
52 WEEK LOW
0.7001
MARKET CAP
66.37M
P/E (TTM)
-1.8449
1D
5D
1M
3M
1Y
5Y
1D
Clearside Biomedical announces six presentations related to CLS-AX
TipRanks · 10h ago
Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
Barchart · 15h ago
Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
Barchart · 1d ago
Protagonist Therapeutics (PTGX) Reports Q1 Loss, Tops Revenue Estimates
NASDAQ · 2d ago
Weekly Report: what happened at CLSD last week (0428-0502)?
Weekly Report · 4d ago
Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference
Barchart · 05/01 06:05
Weekly Report: what happened at CLSD last week (0421-0425)?
Weekly Report · 04/28 09:57
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 04/23 21:05
More
About CLSD
More
Clearside Biomedical, Inc. is a biopharmaceutical company focused on the delivery of therapies to the back of the eye through the suprachoroidal space (SCS). The Company's SCS injection platform, utilizing its patented SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. The Company is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector. The Company's lead program, CLS-AX (axitinib injectable suspension), for the treatment of neovascular age-related macular degeneration (wet AMD). It developed and gained approval for its product, XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use, which is available in the United States through a commercial partner.
Recently
Symbol
Price
%Change

Webull offers Clearside Biomedical Inc stock information, including NASDAQ: CLSD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLSD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLSD stock methods without spending real money on the virtual paper trading platform.